RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재

    Myeloablative Hematopoietic Stem Cell Transplantation with a Non-total Body Irradiation Regimen for Treating Pediatric Acute Lymphoblastic Leukemia

    한글로보기

    https://www.riss.kr/link?id=A106148588

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Background: Total body irradiation (TBI) has been traditionally used as a conditioning regimen prior to hematopoietic stem cell transplantation (HSCT) in patients with pediatric leukemia. However, TBI can cause late sequelae such as growth impairment, cataract, hormone abnormalities, infertility, neurocognitive effects, and secondary malignancy in pediatric patients.
    Methods: This single center retrospective study included 22 patients with acute lymphoblastic leukemia who were aged <18 years and underwent HSCT between May 1999 and December 2014; seven patients received a TBI-based regimen and 15 received a non-TBI regimen.
    Results: The overall survival and event-free survival rates in the TBI group were not significantly different from those in the non-TBI group (overall survival rate 71% vs. 73%, respectively; P=0.906; event-free survival rate 71% vs. 73%, respectively P=0.923).
    Conclusion: Our results indicate that non-TBI conditioning regimens can be an alternative treatment option of the treatment of pediatric acute lymphoblastic leukemia undergoing HSCT.
    번역하기

    Background: Total body irradiation (TBI) has been traditionally used as a conditioning regimen prior to hematopoietic stem cell transplantation (HSCT) in patients with pediatric leukemia. However, TBI can cause late sequelae such as growth impairment,...

    Background: Total body irradiation (TBI) has been traditionally used as a conditioning regimen prior to hematopoietic stem cell transplantation (HSCT) in patients with pediatric leukemia. However, TBI can cause late sequelae such as growth impairment, cataract, hormone abnormalities, infertility, neurocognitive effects, and secondary malignancy in pediatric patients.
    Methods: This single center retrospective study included 22 patients with acute lymphoblastic leukemia who were aged <18 years and underwent HSCT between May 1999 and December 2014; seven patients received a TBI-based regimen and 15 received a non-TBI regimen.
    Results: The overall survival and event-free survival rates in the TBI group were not significantly different from those in the non-TBI group (overall survival rate 71% vs. 73%, respectively; P=0.906; event-free survival rate 71% vs. 73%, respectively P=0.923).
    Conclusion: Our results indicate that non-TBI conditioning regimens can be an alternative treatment option of the treatment of pediatric acute lymphoblastic leukemia undergoing HSCT.

    더보기

    참고문헌 (Reference)

    1 김상정, "소아 백혈병 환자의 동종 조혈모세포이식 전처치로서 전신방사선 조사 포함군과 비포함군의 비교" 대한소아과학회 53 (53): 538-547, 2010

    2 Tracey J, "Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia" 19 : 255-259, 2013

    3 Chessells JM, "The management of high-risk lymphoblastic leukaemia in children" 108 : 204-216, 2000

    4 Sanders JE, "The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team" 28 : 244-249, 1991

    5 Santos GW, "The development of busulfan/cyclophosphamide preparative regimens" 20 (20): 12-16, 1993

    6 Mori T, "Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia" 87 : 349-353, 2012

    7 Bunin N, "Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study" 32 : 543-548, 2003

    8 Santos GW, "Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia" 53 : 1781-1785, 1974

    9 Bhatia S, "Malignant neoplasms following bone marrow transplantation" 87 : 3633-3639, 1996

    10 Gaynon PS, "Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report" 24 : 285-297, 2010

    1 김상정, "소아 백혈병 환자의 동종 조혈모세포이식 전처치로서 전신방사선 조사 포함군과 비포함군의 비교" 대한소아과학회 53 (53): 538-547, 2010

    2 Tracey J, "Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia" 19 : 255-259, 2013

    3 Chessells JM, "The management of high-risk lymphoblastic leukaemia in children" 108 : 204-216, 2000

    4 Sanders JE, "The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team" 28 : 244-249, 1991

    5 Santos GW, "The development of busulfan/cyclophosphamide preparative regimens" 20 (20): 12-16, 1993

    6 Mori T, "Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia" 87 : 349-353, 2012

    7 Bunin N, "Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study" 32 : 543-548, 2003

    8 Santos GW, "Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia" 53 : 1781-1785, 1974

    9 Bhatia S, "Malignant neoplasms following bone marrow transplantation" 87 : 3633-3639, 1996

    10 Gaynon PS, "Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report" 24 : 285-297, 2010

    11 Locatelli F, "Late effects in children after bone marrow transplantation: a review" 78 : 319-328, 1993

    12 Granados E, "Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation" 85 : 1060-1067, 2000

    13 Cohen A, "Growth in patients after allogeneic bone marrow transplant for hematological diseases in childhood" 15 : 343-348, 1995

    14 Shankar SM, "Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning" 18 : 362-366, 1996

    15 Sanders JE, "Growth and development after hematopoietic cell transplant in children" 41 : 223-227, 2008

    16 Legault L, "Endocrine complications of bone marrow transplantation in children" 3 : 60-66, 1999

    17 Jongmoo Park, "Effects of total body irradiation-based conditioning on allogeneic stem cell transplantation for pediatric acute leukemia: a single-institution study" 대한방사선종양학회 32 (32): 198-207, 2014

    18 Davies SM, "Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia" 18 : 340-347, 2000

    19 Shulman HM, "Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients" 69 : 204-217, 1980

    20 Ciurea SO, "Busulfan in hematopoietic stem cell transplantation" 15 : 523-536, 2009

    21 Thomas ED, "Bone marrow transplantation in hematologic malignancies" 22 : 77-91, 1987

    22 Wolden SL, "American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI)" 36 : 97-101, 2013

    23 Hunger SP, "Acute lymphoblastic leukemia in children" 373 : 1541-1552, 2015

    24 Ringdén O, "A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group" 83 : 2723-2730, 1994

    25 Przepiorka D, "1994 Consensus Conference on Acute GVHD Grading" 15 : 825-828, 1995

    더보기

    동일학술지(권/호) 다른 논문

    동일학술지 더보기

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 재인증평가 신청대상 (재인증)
    2020-01-01 등재 등재학술지 선정 (재인증) KCI등재
    2019-12-01 등재 등재후보로 하락 (계속평가) KCI등재후보
    2016-01-01 등재 등재학술지 선정 (계속평가) KCI등재
    2014-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.1 0.1 0
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0 0 0 0
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼